review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/HEP.21949 |
P698 | PubMed publication ID | 17969053 |
P50 | author | Joseph A Murray | Q56559210 |
P2093 | author name string | Alberto Rubio-Tapia | |
P2860 | cites work | Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete | Q24806327 |
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations | Q28137734 | ||
Celiac disease and recurrent pancreatitis | Q28138325 | ||
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis | Q28211823 | ||
Nonalcoholic fatty liver disease | Q29619354 | ||
Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data | Q30573244 | ||
Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature | Q33539162 | ||
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease | Q33998193 | ||
The HLA system. First of two parts | Q34023681 | ||
Celiac sprue | Q34109907 | ||
AGA technical review on the evaluation of liver chemistry tests | Q34152798 | ||
Primary biliary cirrhosis and coeliac disease: an association? | Q34288119 | ||
Bacteria and human autoimmunity: the case of primary biliary cirrhosis | Q34327472 | ||
Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. | Q34328076 | ||
Malignancy and mortality in people with coeliac disease: population based cohort study | Q34335152 | ||
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis | Q34477251 | ||
Cognitive impairment and celiac disease | Q34572686 | ||
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. | Q34579599 | ||
In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. | Q34649501 | ||
Hepatic manifestations of gastrointestinal diseases. Inflammatory bowel disease, celiac disease, and Whipple's disease | Q35040118 | ||
The liver in celiac disease | Q35186017 | ||
The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences | Q35348722 | ||
Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease | Q35365265 | ||
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. | Q35598393 | ||
Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. | Q36041175 | ||
Skin manifestations of celiac disease | Q36095947 | ||
Celiac disease genetics: current concepts and practical applications | Q36290028 | ||
Causes of death in patients with celiac disease in a population-based Swedish cohort | Q38483066 | ||
Intestinal involvement is not sufficient to explain hypertransaminasemia in celiac disease? | Q39347542 | ||
Hepatic injury in adult coeliac disease | Q39446125 | ||
The liver in coeliac disease | Q40165848 | ||
Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis | Q43484025 | ||
Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure | Q43557858 | ||
Interferon-alpha drives T cell-mediated immunopathology in the intestine | Q43690829 | ||
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin | Q43724107 | ||
Primary sclerosing cholangitis with celiac sprue: two cases | Q44041735 | ||
High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies. | Q44362815 | ||
Hepatitis B vaccine nonresponse and celiac disease | Q45208004 | ||
Cirrhosis in children with celiac disease. | Q46586896 | ||
Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease? | Q46798243 | ||
Searching for coeliac disease in patients with non-alcoholic fatty liver disease | Q47361870 | ||
Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease | Q47857569 | ||
Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. | Q50586107 | ||
Onset of coeliac disease during treatment with interferon for chronic hepatitis C. | Q50586402 | ||
Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. | Q50587763 | ||
Inflammatory bowel disease in patients with celiac disease. | Q50767500 | ||
Accuracy of ultrasonography in predicting celiac disease. | Q51532122 | ||
The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease. | Q51541646 | ||
Abnormalities of Serum Cholecystokinin and Gallbladder Emptying in Celiac Disease | Q51673624 | ||
Failure to respond to hepatitis B vaccine in children with celiac disease. | Q53573790 | ||
Obstructive jaundice caused by enteropathy-associated T-cell lymphoma in a patient with celiac sprue. | Q53602101 | ||
Celiac disease associated with autoimmune myocarditis. | Q53763795 | ||
High prevalence of celiac sprue among patients with primary biliary cirrhosis. | Q53845320 | ||
Autoimmune Hepatitis | Q56210456 | ||
Celiac disease in autoimmune cholestatic liver disorders | Q56428274 | ||
Coeliac disease hidden by cryptogenic hypertransaminasaemia | Q57014316 | ||
Celiac Disease and Risk of Liver Disease: A General Population-Based Study | Q57697794 | ||
Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy | Q63203956 | ||
Primary sclerosing cholangitis and celiac disease. A novel association | Q67966813 | ||
Hepatic lesions in adult coeliac disease | Q68909370 | ||
Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by gluten-free diet | Q70044419 | ||
Unsuspected coeliac disease in chronic 'cryptogenic' liver disease | Q72751280 | ||
Precipitation of iron overload and hereditary hemochromatosis after successful treatment of celiac disease | Q73363132 | ||
Adult celiac disease and hemochromatosis | Q73382970 | ||
Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict coeliac disease in patients with chronic liver disease | Q73942601 | ||
Gluten sensitivity in patients with primary biliary cirrhosis | Q74526459 | ||
Chronic unexplained hypertransaminasemia may be caused by occult celiac disease | Q74529905 | ||
Adult celiac disease: US signs | Q77400824 | ||
Prevalence and clinical importance of hypertransaminasaemia in coeliac disease | Q77763274 | ||
HLA-DQ typing in the diagnosis of celiac disease | Q77845009 | ||
Celiac disease during interferon treatment | Q78037659 | ||
Small bowel ultrasound in patients with celiac disease. Retrospective study | Q79869820 | ||
Celiac disease is not associated with chronic hepatitis C | Q79988541 | ||
Abnormal intestinal permeability in primary biliary cirrhosis | Q80177198 | ||
Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome | Q80880115 | ||
False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent | Q81814604 | ||
Association of celiac disease with non-cirrhotic portal fibrosis | Q82478548 | ||
High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source | Q95812923 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1650-1658 | |
P577 | publication date | 2007-11-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | The liver in celiac disease | |
P478 | volume | 46 |
Q80998677 | A 10-year-old girl with mild elevation of liver transaminases |
Q33457749 | ACG clinical guidelines: diagnosis and management of celiac disease |
Q48773629 | Adult coeliac disease in Ireland: a case series |
Q27693707 | Antibodies in celiac disease: implications beyond diagnostics. |
Q42144647 | Association of Autoimmune Hepatitis and Celiac Disease: Role of Gluten-Free Diet in Reversing Liver Dysfunction |
Q27489093 | Autoantibodies in primary sclerosing cholangitis |
Q41700393 | Autoimmune Hepatitis and Celiac Disease: Case Report Showing an Entero-Hepatic Link |
Q90009862 | Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications |
Q38919389 | Celiac Disease: Role of the Epithelial Barrier |
Q37171296 | Celiac disease and autoimmunity in the gut and elsewhere |
Q28290840 | Celiac disease and autoimmunity: review and controversies |
Q41786158 | Celiac disease and cardiomyopathy in an adolescent with occult cirrhosis. |
Q40820511 | Celiac disease and liver. |
Q42736897 | Celiac disease beyond the gut. |
Q36026995 | Celiac disease diagnosis and management: a 46-year-old woman with anemia |
Q36410388 | Celiac disease markers in patients with liver diseases: a single center large scale screening study |
Q84778425 | Celiac disease suspected at endoscopy in patients with chronic liver disease |
Q30234291 | Celiac disease: From pathophysiology to treatment |
Q45383579 | Clinical features of chronic C virus hepatitis in patients with celiac disease. |
Q28242747 | Coeliac disease |
Q28266589 | Coeliac disease and autoimmune disease-genetic overlap and screening |
Q35507149 | Commentary on the article: Are hepatitis B virus and celiac disease linked?: HBV and celiac disease. |
Q82845344 | Complications in celiac disease under gluten-free diet |
Q30450710 | Cryptogenic cirrhosis: what are we missing? |
Q24324593 | Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases |
Q97529137 | Discordance Between Serology and Histology for Celiac Disease in a Cohort with Coexisting Liver Disorders |
Q46640123 | Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report |
Q34489030 | Extraintestinal manifestations of coeliac disease |
Q42342728 | Gluten-Free hepatomiracle in "celiac hepatitis": A case highlighting the rare occurrence of nutrition-induced near total reversal of advanced steatohepatitis and cirrhosis |
Q93198074 | Glycogenic Hepatopathy: A Rare Hepatic Complication of Poorly Controlled Type 1 DM |
Q85663139 | Gut-liver axis and disease infidelity: a subject worth exploring |
Q30887448 | Hepatic hemangioma in celiac patients: data from a large consecutive series |
Q34329062 | Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow |
Q37812845 | Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders |
Q38368198 | Hepatobiliary disorders in celiac disease: an update |
Q37397006 | Histological abnormalities of the small bowel mucosa in cirrhosis and portal hypertension |
Q34775968 | Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. |
Q35093047 | Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study |
Q35629725 | Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease |
Q42581118 | Is an atypical presentation becoming typical of coeliac disease? |
Q35540224 | Liver complications in celiac disease |
Q41994459 | Liver involvement in celiac disease |
Q90005438 | Liver pathology in children with newly diagnosed celiac disease |
Q36558287 | Microbial translocation in the pathogenesis of HIV infection and AIDS. |
Q33734125 | PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease |
Q35642787 | Prevalence of Celiac Disease in Children with Autoimmune Hepatitis and vice versa. |
Q40762887 | Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population |
Q37799533 | Primary sclerosing cholangitis: overview and update |
Q41909367 | Rhinacanthus nasutus Improves the Levels of Liver Carbohydrate, Protein, Glycogen, and Liver Markers in Streptozotocin-Induced Diabetic Rats. |
Q39022693 | Screening for celiac disease, by endomysial antibodies, in patients with unexplained articular manifestations |
Q27008041 | Systemic causes of cholestasis |
Q92855679 | The Liver and Celiac Disease |
Q26778458 | The Spectrum of Differences between Childhood and Adulthood Celiac Disease |
Q34392659 | The role of celiac disease in severity of liver disorders and effect of a gluten free diet on diseases improvement |
Q34551744 | To screen or not to screen? Celiac antibodies in liver diseases |
Search more.